A PLN founder mutation, PLN p.R14del, was identified in large European cohorts, including 10–15% of Dutch patients with ARVC or DCM, and was associated with high mortality and poor prognosis10, 12. This evidence concerns the gene PLN and arrhythmogenic right ventricular cardiomyopathy.